Simplex Trading’s Dianthus Therapeutics DNTH Stock Holding History

Simplex Trading’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$585K	Buy	6,000 +4,700	+362%	+$411K	﹤0.01%	3403
2026 Q1	$109K	Sell	1,300 -39,700	-97%	-$2.3M	﹤0.01%	4979
2025 Q4	$1.69M	Buy	41,000 +30,400	+287%	+$1.18M	﹤0.01%	2118
2025 Q3	$417K	Buy	10,600 +5,600	+112%	+$143K	﹤0.01%	4053
2025 Q2	$93K	Buy	5,000 +200	+4%	+$3.75K	﹤0.01%	5308
2025 Q1	$87K	Buy	+4,800	New	+$106K	﹤0.01%	5191
2023 Q2	–	Sell	-363	Closed	-$4K	–	9171
2023 Q1	$4K	Buy	+363	New	+$4.02K	﹤0.01%	8158
2022 Q2	–	Sell	-44	Closed	-$2K	–	10156
2022 Q1	$2K	Hold	44	–	–	﹤0.01%	9835
2021 Q4	$3K	Buy	+44	New	+$4.42K	﹤0.01%	9808
2020 Q3	–	Hold	0	–	-$3K	–	7917
2020 Q2	–	Hold	0	–	–	–	7135

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Simplex Trading's DNTH Position: Q2 2026 in Review

Simplex Trading reduced its Dianthus Therapeutics (DNTH) stake by 15% in Q2 2026, selling an estimated $24.5K and leaving 1,594 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #5034.

Simplex Trading first reported a position in DNTH in Q4 2019 and has held it in 17 quarters since. The position peaked at $714K in Q4 2025. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Simplex Trading held 1,594 shares of Dianthus Therapeutics worth $155K as of Q2 2026.
Simplex Trading sold 281 Dianthus Therapeutics shares in Q2 2026, an estimated $24.5K.
Dianthus Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5034 holding.
Simplex Trading first reported a position in Dianthus Therapeutics in Q4 2019 and has held it in 17 quarters since.
Simplex Trading's Dianthus Therapeutics position peaked at $714K in Q4 2025.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.